|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Roger_Perlmutter
|
|
gptkbp:focus
|
drug discovery
|
|
gptkbp:foundedYear
|
2019
|
|
gptkbp:founder
|
gptkb:Xiaowei_Zhuang
gptkb:Eric_Betzig
gptkb:Xiaoliang_Sunney_Xie
gptkb:Luke_Lavis
gptkb:Robert_Tjian
|
|
gptkbp:fundedBy
|
$148 million Series A (2021)
$518 million Series B (2022)
|
|
gptkbp:headquartersLocation
|
gptkb:Hayward,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Eikon Therapeutics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:notableAdvisor
|
gptkb:David_Baltimore
gptkb:Jennifer_Doudna
gptkb:Marc_Tessier-Lavigne
gptkb:Xiaowei_Zhuang
gptkb:Eric_Betzig
gptkb:Robert_Tjian
gptkb:David_Goeddel
gptkb:Richard_Scheller
|
|
gptkbp:notableInvestment
|
gptkb:EcoR1_Capital
gptkb:Omega_Funds
gptkb:Qiming_Venture_Partners
gptkb:Foresite_Capital
gptkb:SoftBank_Vision_Fund_2
gptkb:Casdin_Capital
gptkb:WuXi_AppTec
gptkb:Fidelity_Management_&_Research
gptkb:Horizons_Ventures
gptkb:T._Rowe_Price
gptkb:Viking_Global_Investors
gptkb:Lilly_Asia_Ventures
gptkb:Prosperity7_Ventures
gptkb:The_Column_Group
gptkb:Tavistock_Group
gptkb:Innovation_Endeavors
gptkb:Sands_Capital
gptkb:Altimeter_Capital
gptkb:ARCH_Venture_Partners
gptkb:Hummingbird_Ventures
Section 32
|
|
gptkbp:numberOfEmployees
|
over 300 (as of 2023)
|
|
gptkbp:technology
|
super-resolution microscopy
live-cell imaging
|
|
gptkbp:website
|
https://www.eikontx.com/
|
|
gptkbp:bfsParent
|
gptkb:Lux_Capital
|
|
gptkbp:bfsLayer
|
5
|